The Latest Breaking News from Mizuho

Despite Palantir's impressive 66% surge this year, Mizuho downgraded the stock to 'Underperform' due to concerns over high valuation and limited earnings visibility. With mixed analyst ratings and the Q2 earnings report approaching, investors are advised to tread carefully and prepare for potential volatility.

Brokerage firm Mizuho says this energy stock sits at the 'data center crossroads' of America - which is a good spot to be right now, as AI drives an exponential surge in energy demand.

AES Corporation has underperformed the broader market YTD, but Wall Street analysts are highly optimistic about the stock’s prospects.

Among world’s top 60 banks those in US are biggest fossil fuel financiers, while Barclays leads way in Europe

Integrating juniors was the plan from the start for this purpose-driven event.

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing drugs to combat obesity. Is TERN stock a good buy right now?

With a 2024 loss approaching 30%, former SPAC name SoFi is among the worst-performing stocks this year. However, Truist thinks the stock can nearly double from these levels. Here's the forecast for this fintech company after its recent sell-off.

Discover how Mizuho, a top financial institution in Japan, aims to maintain its global investment banking status through expansion and innovation.

Discover Mizuho's strong performance in the Q3, with an 8.2% increase in profit driven by their robust lending business in Japan.